Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,961 to 1,980 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cortactin and fascin-1 regulate extracellular vesicle release by controlling endosomal trafficking or invadopodia formation and function. | Sci Rep | 2018 | 30353022 | PubTator, text mining | PubMed |
| Sporadic and Hereditary Breast Cancer Genetics. | Radiol Technol | 2018 | 30352929 | PubTator, text mining | PubMed |
| ERK phosphorylation functions in invadopodia formation in tongue cancer cells in a novel silicate fibre-based 3D cell culture system. | Int J Oral Sci | 2018 | 30344309 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Matrix Remodeling Enzymes: The Emerging Roles in Extracellular Matrix Remodeling, Progression of Diseases and Tissue Repair. | Cells | 2018 | 30322133 | PubTator, text mining | PubMed |
| Ethanol-Induced Behavioral Sensitization Alters the Synaptic Transcriptome and Exon Utilization in DBA/2J Mice. | Front Genet | 2018 | 30319688 | PubTator, text mining | PubMed |
| Flavivirus Receptors: Diversity, Identity, and Cell Entry. | Front Immunol | 2018 | 30319635 | PubTator, text mining | PubMed |
| Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF). | PLoS One | 2018 | 30312303 | PubTator, text mining | PubMed |
| Matrix mechanical plasticity regulates cancer cell migration through confining microenvironments. | Nat Commun | 2018 | 30297715 | PubTator, text mining | PubMed |
| Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2', 4'-Tetrahydroxychalcone. | J Exp Clin Cancer Res | 2018 | 30285892 | PubTator, text mining | PubMed |
| N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer. | BMC Cancer | 2018 | 30285678 | PubTator, text mining | PubMed |
| Abl2 is recruited to ventral actin waves through cytoskeletal interactions to promote lamellipodium extension. | Mol Biol Cell | 2018 | 30256707 | PubTator, text mining | PubMed |
| Priming the seed: Helicobacter pylori alters epithelial cell invasiveness in early gastric carcinogenesis. | World J Gastrointest Oncol | 2018 | 30254719 | PubTator, text mining | PubMed |
| Protein Profile of Blood Monocytes is Altered in HTLV-1 Infected Patients: Implications for HAM/TSP Disease. | Sci Rep | 2018 | 30254298 | PubTator, text mining | PubMed |
| FAK family kinases: The Yin and Yang of cancer cell invasiveness. | Mol Cell Oncol | 2018 | 30250911 | PubTator, text mining | PubMed |
| [Myasthenia gravis: current status of antibody diagnostics and aspects on refractory myasthenia gravis]. | Fortschr Neurol Psychiatr | 2018 | 30248688 | PubTator, text mining | PubMed |
| Stiffness-Induced Endothelial DLC-1 Expression Forces Leukocyte Spreading through Stabilization of the ICAM-1 Adhesome. | Cell Rep | 2018 | 30231995 | PubTator, text mining | PubMed |
| Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines. | Cancers (Basel) | 2018 | 30227653 | PubTator, text mining | PubMed |
| Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells. | Oncotarget | 2018 | 30220969 | PubTator, text mining | PubMed |
| Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells. | Oncotarget | 2018 | 30220968 | PubTator, text mining | PubMed |
| Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs. | Transl Oncol | 2018 | 30219696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=99